Skip to main content
. Author manuscript; available in PMC: 2021 Dec 10.
Published in final edited form as: Pharm Res. 2015 Dec 21;33(4):909–921. doi: 10.1007/s11095-015-1837-5

Figure 1.

Figure 1.

The overall methodology for conducting the CFD simulations is shown. Particle deposition data in the (a) 3D model of the nose from a commercial nasal spray was mapped onto the (b) surface-based model. CFD simulations were conducted using this model and accounted for (c) particle advection due to mucociliary clearance, particle dissolution and diffusion, and drug absorption at the epithelial surface.